Cargando…
Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
SIMPLE SUMMARY: Biochemical inhibition of male sex hormone function (androgen signaling), also known as androgen deprivation therapy (ADT), for human prostate cancer remains a major treatment strategy almost 80 years after the discovery of androgens as a major factor in the disease. Drug development...
Autor principal: | Maitland, Norman J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829888/ https://www.ncbi.nlm.nih.gov/pubmed/33477370 http://dx.doi.org/10.3390/cancers13020327 |
Ejemplares similares
-
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
por: Verma, Shiv, et al.
Publicado: (2020) -
Resistance to Novel Antiandrogen Therapies in Metastatic
Castration-Resistant Prostate Cancer
por: Boudadi, Karim, et al.
Publicado: (2016) -
Role of prostate cancer stem-like cells in the development of antiandrogen resistance
por: Kushwaha, Prem Prakash, et al.
Publicado: (2022) -
Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
por: Congregado Ruiz, Belén, et al.
Publicado: (2023) -
Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives
por: Pinto, Francesco, et al.
Publicado: (2022)